{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:25:20Z","timestamp":1762507520727,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T00:00:00Z","timestamp":1536883200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s12094-018-1944-y","type":"journal-article","created":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T15:33:59Z","timestamp":1536939239000},"page":"451-458","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Goal-directed therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a prospective observational study"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6122-9616","authenticated-orcid":false,"given":"N.","family":"Esteve-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ferrer-Robles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"G\u00f3mez-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Fabi\u00e1n-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Verd-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. C.","family":"Mora-Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. J.","family":"Segura-Sampedro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tejada-Gavela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Morales-Soriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,14]]},"reference":[{"issue":"4","key":"1944_CR1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1159\/000248164","volume":"43","author":"W Raue","year":"2009","unstructured":"Raue W, Tsilimparis N, Bloch A, Menenakos C, Hartmann J. Volume therapy and cardiocircular function during hyperthermic intraperitoneal chemotherapy. Eur Surg Res. 2009;43(4):365\u201372.","journal-title":"Eur Surg Res"},{"key":"1944_CR2","doi-asserted-by":"publisher","DOI":"10.11622\/smedj.2016078","author":"SY Thong","year":"2016","unstructured":"Thong SY, Chia CS, Ng O, Tan G, Ong ET, Soo KC, Teo M. A review of 111 anaesthetic patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Singap Med J. 2016. https:\/\/doi.org\/10.11622\/smedj.2016078 [Epub ahead of print].","journal-title":"Singap Med J"},{"issue":"12","key":"1944_CR3","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1111\/codi.12444","volume":"15","author":"K Thanigaimani","year":"2013","unstructured":"Thanigaimani K, Mohamed F, Cecil T, Moran BJ, Bell J. The use of cardiac output monitoring to guide the administration of intravenous fluid during hyperthermic intraperitoneal chemotherapy. Colorectal Dis. 2013;15(12):1537\u201342.","journal-title":"Colorectal Dis"},{"key":"1944_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00404-014-3153-4","volume":"290","author":"J Pascual","year":"2014","unstructured":"Pascual J, Sanchez S, Gonzalez F, Villarejo P, L\u00f3pez de la Manzanara C, Haya J, Padilla D, Martin J. Security and efficiency of a closed-system, turbulent-flow circuit for HIPEC after cytoreductive ovar\u00edan surgery: perioperative outputs. Arch Gynecol Obstet. 2014;290:121\u20139.","journal-title":"Arch Gynecol Obstet"},{"key":"1944_CR5","first-page":"1","volume":"8","author":"O Korakianitis","year":"2015","unstructured":"Korakianitis O, Daskalou T, Alevizos L, Stamou K, Mavroudis C, Iatrou C, Vogiatzaki T, Eleftheriadis S, Tentes AA. Lack of significant intraoperative coagulopathy in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) indicates that epidural anaesthesia is a safe option. Int J Hyperthermia. 2015;8:1\u20136.","journal-title":"Int J Hyperthermia"},{"issue":"8","key":"1944_CR6","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ciresp.2015.01.012","volume":"93","author":"L Falc\u00f3n Ara\u00f1a","year":"2015","unstructured":"Falc\u00f3n Ara\u00f1a L, Fuentes-Garc\u00eda D, Roca Calvo MJ, Hern\u00e1ndez-Palaz\u00f3n J, Gil Mart\u00ednez J, Cascales Campos PA, Acosta Villegas FJ, Parrilla Paricio P. Alterations in hemostasis during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis. Cir Esp. 2015;93(8):496\u2013501.","journal-title":"Cir Esp"},{"issue":"2","key":"1944_CR7","first-page":"160","volume":"82","author":"CN Schluermann","year":"2016","unstructured":"Schluermann CN, Hoeppner J, Benk C, Schmidt R, Loop T, Kalbhenn J. Intraabdominal pressure, cardiac index and vascular resistance during hyperthermic intraperitoneal chemotherapy: a prospective observational study. Minerva Anestesiol. 2016;82(2):160\u20139.","journal-title":"Minerva Anestesiol"},{"issue":"3","key":"1944_CR8","first-page":"310","volume":"82","author":"F Coccolini","year":"2016","unstructured":"Coccolini F, Corbella D, Finazzi P, Brambillasca P, Benigni A, Prussiani V, Ceresoli M, Manfredi R, Poiasina E, Bertoli P, Catena F, Bianchetti A, Bontempelli M, Lorini LF, Sonzogni V, Ansaloni L. Time course of cytokines, hemodynamic and metabolic parameters during hyperthermic intraperitoneal chemotherapy. Minerva Anestesiol. 2016;82(3):310\u20139.","journal-title":"Minerva Anestesiol"},{"issue":"4","key":"1944_CR9","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s11605-015-2743-1","volume":"19","author":"L Colantonio","year":"2015","unstructured":"Colantonio L, Claroni C, Fabrizi L, Marcelli ME, Sofra M, Giannarelli D, Garofalo A, Forastiere E. A randomized trial of goal directed vs standard fluid therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. J Gastrointest Surg. 2015;19(4):722\u20139.","journal-title":"J Gastrointest Surg"},{"key":"1944_CR10","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/SLA.0000000000001366","volume":"263","author":"KE Rollins","year":"2016","unstructured":"Rollins KE, Lobo DN. Intraoperative goal-directed fluid therapy in elective major abdominal surgery: a meta-analysis of randomized controlled trials. Ann Surg. 2016;263:465\u201376.","journal-title":"Ann Surg"},{"key":"1944_CR11","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1001\/jama.2014.5305","volume":"311","author":"RM Pearse","year":"2014","unstructured":"Pearse RM, Harrison DA, MacDonald N, Gillies MA, Blunt M, Ackland G, Grocott MP, Ahern A, Griggs K, Scott R, Hinds C, Rowan K, OPTIMISE Study Group. Effect of a perioperative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery: a randomized clinical trial and systematic review. JAMA. 2014;311:2181\u201390.","journal-title":"JAMA"},{"key":"1944_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201313.","journal-title":"Ann Surg"},{"issue":"4","key":"1944_CR13","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1177\/0310057X1704500413","volume":"45","author":"SP Shiralkar","year":"2017","unstructured":"Shiralkar SP, Kerr P, Scott J, Sivalingam P. Anaesthetic management of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei: a retrospective audit. Anaesth Intensive Care. 2017;45(4):490\u20138.","journal-title":"Anaesth Intensive Care"},{"issue":"12","key":"1944_CR14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/1477-7819-12-136","volume":"1","author":"ME Kajdi","year":"2014","unstructured":"Kajdi ME, Beck-Schimmer B, Held U, Kofmehl R, Lehmann K, Ganter MT. Anaesthesia in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: retrospective analysis of a single centre three-year experience. World J Surg Oncol. 2014;1(12):136.","journal-title":"World J Surg Oncol"},{"issue":"6","key":"1944_CR15","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.9738\/INTSURG-D-14-00138.1","volume":"100","author":"C Mavroudis","year":"2015","unstructured":"Mavroudis C, Alevizos L, Stamou K, Vogiatzaki T, Eleftheriadis S, Korakianitis O, Tentes A, Iatrou C. Hemodynamic monitoring during heated intraoperative intraperitoneal chemotherapy using the FloTrac\/Vigileo\u2122 system. Int Surg. 2015;100(6):1033\u20139.","journal-title":"Int Surg"},{"key":"1944_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08941939.2016.1204386","volume":"30","author":"FJ Redondo","year":"2017","unstructured":"Redondo FJ, Padilla D, Villarejo P, Baladron V, Faba P, S\u00e1nchez S, Mu\u00f1oz-Rodr\u00edguez JR, Bejarano N. The global end-diastolic volume (GEDV) could be more appropiate to fluid management than central venous pressure (CVP) during closed hyperthermic intrabdominal chemotherapy with CO2 circulation. J Invest Surg. 2017;30:1\u20137.","journal-title":"J Invest Surg"},{"issue":"13","key":"1944_CR17","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.1245\/s10434-012-2496-y","volume":"19","author":"JC Bell","year":"2012","unstructured":"Bell JC, Rylah BG, Chambers RW, Peet H, Mohamed F, Moran BJ. Perioperative management of patients undergoing cytoreductive surgery combined with heated intraperitoneal chemotherapy for peritoneal surface malignancy: a multi-institutional experience. Ann Surg Oncol. 2012;19(13):4244\u201351.","journal-title":"Ann Surg Oncol"},{"key":"1944_CR18","unstructured":"Morales-Soriano R, Esteve-P\u00e9rez N, Segura-Sampedro JJ, Cascales-Campos P, Barrios P; Spanish Group of peritoneal malignancy surface (GECOP). Current practice in cytoreductive surgery and HIPEC for metastatic peritoneal disease: Spanish multicentric survey. Eur J Surg Oncol. 2017. pii: S0748-7983(17)30974-5"},{"issue":"5","key":"1944_CR19","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1245\/s10434-013-3221-1","volume":"21","author":"P Owusu-Agyemang","year":"2014","unstructured":"Owusu-Agyemang P, Soliz J, Hayes-Jordan A, Harun N, Gottumukkala V. Safety of epidural analgesia in the perioperative care of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2014;21(5):1487\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"1944_CR20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/AJP.0000000000000393","volume":"33","author":"MM Roeb","year":"2017","unstructured":"Roeb MM, Wolf A, Gr\u00e4ber SS, Meiner W, Volk T. Epidural versus systemic analgesia: an international registry analysis on postoperative pain and related perceptions after abdominal surgery. Clin J Pain. 2017;33(3):189\u201397.","journal-title":"Clin J Pain"},{"issue":"3","key":"1944_CR21","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1213\/ANE.0000000000000245","volume":"119","author":"F Kooij","year":"2014","unstructured":"Kooij F, Schlack WS, Preckel B, Hollmann MW. Does regional analgesia for major surgery improve outcome?. Focus on epidural analgesia. Anesth Analg. 2014;119(3):740\u20134.","journal-title":"Anesth Analg"},{"key":"1944_CR22","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1245\/s10434-016-5665-6","volume":"24","author":"AM Mehta","year":"2017","unstructured":"Mehta AM, Huitema AD, Burger JW, Brandt-Kerkhof AR, van den Heuvel SF, Verwaal VJ. Standard clinical protocol for bidirectional hyperthermic intraperitoneal chemotherapy (HIPEC): systemic leucovorin, 5-fluorouracil, and heated intraperitoneal oxaliplatin in a chloride-containing carrier solution. Ann Surg Oncol. 2017;24:990\u20137.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"1944_CR23","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.ejso.2015.12.016","volume":"42","author":"A Arjona-S\u00e1nchez","year":"2016","unstructured":"Arjona-S\u00e1nchez A, Cadenas-Febres A, Cabrera-Bermon J, Mu\u00f1oz-Casares FC, Casado-Adam A, S\u00e1nchez-Hidalgo JM, L\u00f3pez-Andreu M, Brice\u00f1o-Delgado J, Rufi\u00e1n-Pe\u00f1a S. Assessment of RIFLE and AKIN criteria to define acute renal dysfunction for HIPEC procedures for ovarian and non-ovarian peritoneal malignances. Eur J Surg Oncol. 2016;42(6):869\u201376.","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"1944_CR24","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.3109\/0886022X.2014.949758","volume":"36","author":"HA Hakeam","year":"2014","unstructured":"Hakeam HA, Breakiet M, Azzam A, Nadeem A, Amin T. The incidence of cisplatin nephrotoxicity post hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery. Ren Fail. 2014;36(10):1486\u201391.","journal-title":"Ren Fail"},{"key":"1944_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.5049\/EBP.2014.12.2.55","volume":"12","author":"GS Oh","year":"2014","unstructured":"Oh GS, Kim HJ, Shen A, Lee SB, Khadka D, Pandit A, So HS. Cisplatin-induced kidney dysfunction and perspectives on improving treatment strategies. Electrolyte Blood Press. 2014;12:55\u201365.","journal-title":"Electrolyte Blood Press"},{"issue":"1","key":"1944_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/cc11454","volume":"17","author":"JA Kellum","year":"2013","unstructured":"Kellum JA, Lameire N, KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013;17(1):20.","journal-title":"Crit Care"},{"issue":"9","key":"1944_CR27","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1245\/s10434-017-5869-4","volume":"24","author":"OS Eng","year":"2017","unstructured":"Eng OS, Dumitra S, O\u2019Leary M, Wakabayashi M, Dellinger TH, Han ES, Lee SJ, Paz IB, Lee B. Base excess as a predictor of complications in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2017;24(9):2707\u201311.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"1944_CR28","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1245\/s10434-015-5012-3","volume":"23","author":"JM Baumgartner","year":"2016","unstructured":"Baumgartner JM, Kwong TG, Ma GL, Messer K, Kelly KJ, Lowy AM. A novel tool for predicting major complications after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2016;23(5):1609\u201317.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"1944_CR29","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1001\/jamasurg.2013.3640","volume":"149","author":"MD Jafari","year":"2014","unstructured":"Jafari MD, Halabi WJ, Stamos MJ, Nguyen VQ, Carmichael JC, Mills SD, Pigazzi A. Surgical outcomes of hyperthermic intraperitoneal chemotherapy: analysis of the American College of Surgeons National Surgical Quality Improvement Program. JAMA Surg. 2014;149(2):170\u20135.","journal-title":"JAMA Surg"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-018-1944-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-018-1944-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-018-1944-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T11:53:02Z","timestamp":1662033182000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-018-1944-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,14]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["1944"],"URL":"https:\/\/doi.org\/10.1007\/s12094-018-1944-y","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"type":"print","value":"1699-048X"},{"type":"electronic","value":"1699-3055"}],"subject":[],"published":{"date-parts":[[2018,9,14]]},"assertion":[{"value":"15 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Drs. Neus Esteve P\u00e9rez, Ana Ferrer-Robles, Germ\u00e1n G\u00f3mez-Romero, David Fabi\u00e1n-Gonzalez, Mateo Verd-Rodriguez, Luis Carlos Mora-Fern\u00e1ndez, Rafael Morales-Soriano, Juan Jos\u00e9 Segura-Sampedro, and Silvia Tejada-Gavela have no conflicts of interest or financial ties to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Clinical Investigation Ethical Committee of the Balearic Islands Government (Palma de Mallorca, Balearic Islands, Spain) with number IB 2381\/14. The protocol procedures were designed in compliance with the clinical research recommendations of the 1964 Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Standard"}},{"value":"This article does not contain any study with animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants or animals"}},{"value":"All participants were informed about the research protocol before giving their written consent to participate in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}